论文信息 - Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis. - 字舞流文

Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.

J. Silverberg | S. Pillai | E. Simpson | A. Blauvelt | A. Irvine | J. Seneschal | C. Chu | D. Thaçi | E. Guttman‐Yassky | L. Stein Gold | R. Gontijo Lima | E. Guttman-Yassky | Zhuqing Liu